Pertussis Vaccine Global Market Report 2024

Pertussis Vaccine Global Market Report 2024 – By Product Type (DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine), By Vaccine Type (Whole-Cell Vaccine, Acellular Vaccine), By Application (Children, Adults, Infants), By End-User (Vaccination Centers, Hospitals, Clinics) – Market Size, Trends, And Global Forecast 2024-2033

Pertussis Vaccine Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Pertussis Vaccine Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

Pertussis Vaccine Market Definition

The pertussis vaccine refers to a vaccine that protects against whooping cough (pertussis), which is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis. It is designed to stimulate the immune system to produce protective antibodies against the pertussis bacterium, thus reducing the risk of infection and its associated symptoms.

The main products of the pertussis vaccine are DTaP (diphtheria, tetanus and acellular pertussis) vaccine, TDaP (tetanus, diphtheria and pertussis) vaccine. The DTaP vaccine, also known as the DTP vaccine, is a combination vaccine that helps protect against three serious bacterial infections, diphtheria, tetanus and pertussis (whooping cough). They are available as whole-cell vaccines and acellular vaccines and are applied over children, adults and infants by various end-users such as vaccination centers, hospitals and clinics.

Pertussis Vaccine Market Segmentation

The pertussis vaccine market covered in this report is segmented –

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine; Tdap (Tetanus, Diphtheria and Pertussis) Vaccine

2) By Vaccine Type: Whole-Cell Vaccine; Acellular Vaccine

3) By Application: Children; Adults; Infants

4) By End-User: Vaccination Centers; Hospitals; Clinics

Global Pertussis Vaccine Market Size 2023 to 2028: Graph

Pertussis Vaccine Market Size 2024 And Growth Rate

The pertussis vaccine market size has grown steadily in recent years. It will grow from $5.26 billion in 2023 to $5.5 billion in 2024 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to disease prevalence, immunization programs, pediatric vaccination, regulatory approvals.

Pertussis Vaccine Market Growth Forecast

The pertussis vaccine market size is expected to see steady growth in the next few years. It will grow to $6.33 billion in 2028 at a compound annual growth rate (CAGR) of 3.6%. The growth in the forecast period can be attributed to booster vaccination, maternal immunization, immunization for healthcare workers, global health initiatives. Major trends in the forecast period include personalized immunization schedules, combination vaccines, vaccine equity initiatives, digital health for immunization.

Pertussis Vaccine Market Driver: Surge In Childbirth Rates Fuels Growth Of Pertussis Vaccine Market

Rising childbirth rates are driving the growth of the pertussis vaccine market going forward. Childbirth is the term for the act of giving birth to a child. It is the culmination of pregnancy, during which the fetus develops in the mother's uterus and marks the beginning of a new life outside the womb. The pertussis vaccine is primarily used for children because it helps protect them from whooping cough and other severe and potentially deadly diseases. For instance, in May 2022, according to the Center for Disease Control and Prevention (CDC), a US-based government organization, there were 3.66 million births in the US in 2021, compared to 3.61 million in 2020. Furthermore, in 2021, according to Statistics Canada, a Canada-based government agency, in Canada, births increased by 2% from 360,552 in 2020 to 367,684 in 2021. Therefore, the rising childbirth rates are driving the growth of the pertussis vaccine market.

Pertussis Vaccine Market Driver: Increase In Number Of Geriatric Population To Drive The Growth Of Pertussis Vaccine Market

The increasing number of geriatric populations is expected to propel the growth of the pertussis vaccine market. The geriatric population refers to the demographic group consisting of individuals who are elderly or in their later stages of life, typically aged 65 and older. The increasing number of geriatric populations is a major factor in the pertussis vaccine market. As more people live longer, there is an increased demand for the pertussis vaccine to protect older adults from this serious disease. For instance, in October 2022, according to the World Health Organization, a Switzerland-based intergovernmental health organization, the global population of individuals aged 60 years and above is projected to double by 2050, reaching 2.1 billion, while the number of people aged 80 years or older is anticipated to triple from 2020 to 2050, reaching 426 million. Therefore, the increasing geriatric population is driving the growth of the pertussis vaccine market.

Global Pertussis Vaccine Market Major Players

Major players in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd., CSL Limited, Astellas Pharma US Inc., Sanofi Pasteur SA, Mitsubishi Tanabe Pharma America Inc., PT Kalbe Farma Tbk, CSL Seqirus, Walvax Biotechnology Co.Ltd., Biological E. Limited, Serum Institute of India, Bavarian Nordic AS, PT Bio Farma, Bharat Biotech International Limited, Takeda Pharmaceutical Company, Panacea Biotec Limited, Beijing Minhai Biotechnology Co. Ltd., Protein Sciences Corporation, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Gennova Biopharmaceuticals Ltd., Chiron Corporation.

The limited availability restrains the pertussis vaccines market's growth during the forecast period. The limited availability of pertussis vaccines had various negative impacts on their distribution and efficacy, such as limited accessibility to vaccines, heightened costs, decreased demand, delayed or incomplete immunization, and repercussions on a global scale. For instance, in July 2023, according to the United Nations International Children's Emergency Fund (UNICEF), a specialized humanitarian agency, in 2022, an estimated 14.3 million children were not administered any doses of pertussis vaccines (diphtheria-tetanus-pertussis DTP3). Therefore, the limited availability is hindering the growth of the pertussis vaccines market.

Global Pertussis Vaccine Market Trend: Innovative Approvals Bolster Major Companies In The Pertussis Vaccine Market

Major companies operating in the pertussis vaccine market are developing innovative drugs and getting approvals to sustain their position in the market. For instance, in October 2022, GSK plc., a UK-based pharmaceutical and biotechnology company, announced that BOOSTRIX was approved by the U.S. Food and Drug Administration (FDA). BOOSTRIX is a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed (Tdap) vaccine. It is used during pregnancy to prevent pertussis (whooping cough) in newborn infants. It is injected once into the upper arm muscle. Boostrix is safe and effective for pregnant women and their babies. Additionally, it effectively prevents pertussis, including severe cases of the disease.

Pertussis Vaccine Market Merger And Acquisition: Gsk Plc Expands Vaccine Portfolio With Acquisition Of Affinivax Inc

In May 2022, GSK plc, a UK-based pharmaceutical and biotechnology company, acquired Affinivax Inc. for $2.1 billion. With this acquisition, GSK aims to expand its vaccine portfolio, reach more patients, strengthen its vaccine R&D pipeline, provide access to a new, potentially disruptive technology and broaden its scientific footprint in Boston. Affinivax Inc. is a US-based biotechnology company that develops pertussis vaccines.

Regional Outlook For The Global Pertussis Vaccine Market

North America was the largest region in the pertussis vaccine market in 2023. The regions covered in pertussis vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pertussis vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pertussis vaccine market consists of sales of adacel, daptacel, infanrix, kinrix, pediarix, pentacel and quadracel. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The pertussis vaccine market research report is one of a series of new reports from The Business Research Company that provides pertussis vaccine market statistics, including pertussis vaccine industry global market size, regional shares, competitors with a pertussis vaccine market share, detailed pertussis vaccine market segments, market trends and opportunities and any further data you may need to thrive in the pertussis vaccine industry. This pertussis vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Pertussis Vaccine Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $5.5 billion
Revenue Forecast In 2033 $6.33 billion
Growth Rate CAGR of 3.6% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine
2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine
3) By Application: Children, Adults, Infants
4) By End-User: Vaccination Centers, Hospitals, Clinics
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc.; Johnson And Johnson Pvt Ltd.; Merck And Co. Inc.; Novartis AG; GlaxoSmithKline plc; AstraZeneca plc; BioNTech SE; Moderna Inc.; Sinovac Biotech Ltd.; CSL Limited; Astellas Pharma US Inc.; Sanofi Pasteur SA; Mitsubishi Tanabe Pharma America Inc.; PT Kalbe Farma Tbk; CSL Seqirus; Walvax Biotechnology Co.Ltd.; Biological E. Limited; Serum Institute of India; Bavarian Nordic AS; PT Bio Farma; Bharat Biotech International Limited; Takeda Pharmaceutical Company; Panacea Biotec Limited; Beijing Minhai Biotechnology Co. Ltd.; Protein Sciences Corporation; Wuhan Institute of Biological Products; Changchun Changsheng Life Sciences; Changsheng Bio-Technology Co. Ltd.; Gennova Biopharmaceuticals Ltd.; Chiron Corporation
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Pertussis Vaccine Market Characteristics

    3. Pertussis Vaccine Market Trends And Strategies

    4. Pertussis Vaccine Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Pertussis Vaccine Market Size and Growth

    5.1. Global Pertussis Vaccine Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Pertussis Vaccine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Pertussis Vaccine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Pertussis Vaccine Market Segmentation

    6.1. Global Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine

    Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine

    6.2. Global Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Whole-Cell Vaccine

    Acellular Vaccine

    6.3. Global Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Children

    Adults

    Infants

    6.4. Global Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Vaccination Centers

    Hospitals

    Clinics

    7. Pertussis Vaccine Market Regional And Country Analysis

    7.1. Global Pertussis Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Pertussis Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Pertussis Vaccine Market  

    8.1. Asia-Pacific Pertussis Vaccine Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Pertussis Vaccine Market  

    9.1. China Pertussis Vaccine Market Overview  

    9.2. China Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Pertussis Vaccine Market  

    10.1. India Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Pertussis Vaccine Market  

    11.1. Japan Pertussis Vaccine Market Overview  

    11.2. Japan Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Pertussis Vaccine Market  

    12.1. Australia Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Pertussis Vaccine Market  

    13.1. Indonesia Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Pertussis Vaccine Market  

    14.1. South Korea Pertussis Vaccine Market Overview  

    14.2. South Korea Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Pertussis Vaccine Market  

    15.1. Western Europe Pertussis Vaccine Market Overview

    15.2. Western Europe Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Pertussis Vaccine Market  

    16.1. UK Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Pertussis Vaccine Market  

    17.1. Germany Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Pertussis Vaccine Market  

    18.5. France Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Pertussis Vaccine Market  

    19.9. Italy Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Pertussis Vaccine Market  

    20.13. Spain Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Pertussis Vaccine Market  

    21.1. Eastern Europe Pertussis Vaccine Market Overview

    21.2. Eastern Europe Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Pertussis Vaccine Market  

    22.1. Russia Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Pertussis Vaccine Market  

    23.1. North America Pertussis Vaccine Market Overview

    23.2. North America Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Pertussis Vaccine Market  

    24.1. USA Pertussis Vaccine Market Overview

    24.2. USA Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Pertussis Vaccine Market  

    25.1. Canada Pertussis Vaccine Market Overview

    25.2. Canada Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Pertussis Vaccine Market  

    26.1. South America Pertussis Vaccine Market Overview

    26.2. South America Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Pertussis Vaccine Market  

    27.1. Brazil Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Pertussis Vaccine Market  

    28.1. Middle East Pertussis Vaccine Market Overview

    28.2. Middle East Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Pertussis Vaccine Market  

    29.1. Africa Pertussis Vaccine Market Overview

    29.2. Africa Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Pertussis Vaccine Market Competitive Landscape And Company Profiles

    30.1. Pertussis Vaccine Market Competitive Landscape

    30.2. Pertussis Vaccine Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson And Johnson Pvt Ltd.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Merck And Co. Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Novartis AG

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. GlaxoSmithKline plc

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Pertussis Vaccine Market Other Major And Innovative Companies

    31.1. AstraZeneca plc

    31.2. BioNTech SE

    31.3. Moderna Inc.

    31.4. Sinovac Biotech Ltd.

    31.5. CSL Limited

    31.6. Astellas Pharma US Inc.

    31.7. Sanofi Pasteur SA

    31.8. Mitsubishi Tanabe Pharma America Inc.

    31.9. PT Kalbe Farma Tbk

    31.10. CSL Seqirus

    31.11. Walvax Biotechnology Co.Ltd.

    31.12. Biological E. Limited

    31.13. Serum Institute of India

    31.14. Bavarian Nordic AS

    31.15. PT Bio Farma

    32. Global Pertussis Vaccine Market Competitive Benchmarking

    33. Global Pertussis Vaccine Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Pertussis Vaccine Market

    35. Pertussis Vaccine Market Future Outlook and Potential Analysis

    35.1 Pertussis Vaccine Market In 2028 - Countries Offering Most New Opportunities

    35.2 Pertussis Vaccine Market In 2028 - Segments Offering Most New Opportunities

    35.3 Pertussis Vaccine Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Pertussis Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Pertussis Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Pfizer Inc. Financial Performance
  • Table 76: Johnson And Johnson Pvt Ltd. Financial Performance
  • Table 77: Merck And Co. Inc. Financial Performance
  • Table 78: Novartis AG Financial Performance
  • Table 79: GlaxoSmithKline plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Pertussis Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Pertussis Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Pfizer Inc. Financial Performance
  • Figure 76: Johnson And Johnson Pvt Ltd. Financial Performance
  • Figure 77: Merck And Co. Inc. Financial Performance
  • Figure 78: Novartis AG Financial Performance
  • Figure 79: GlaxoSmithKline plc Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the pertussis vaccine market?

The pertussis vaccine refers to a vaccine that protects against whooping cough (pertussis), which is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis. It is designed to stimulate the immune system to produce protective antibodies against the pertussis bacterium, thus reducing the risk of infection and its associated symptoms. request a sample here

How will the pertussis vaccine market drivers and restraints affect the pertussis vaccine market dynamics? What forces will shape the pertussis vaccine industry going forward?

The pertussis vaccine market major growth driver - Surge In Childbirth Rates Fuels Growth Of Pertussis Vaccine Market. request a sample here

What is the forecast market size or the forecast market value of the pertussis vaccine market?

The pertussis vaccine market size has grown steadily in recent years. It will grow from $5.26 billion in 2023 to $5.5 billion in 2024 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to disease prevalence, immunization programs, pediatric vaccination, regulatory approvals. The pertussis vaccine market size is expected to see steady growth in the next few years. It will grow to $6.33 billion in 2028 at a compound annual growth rate (CAGR) of 3.6%. The growth in the forecast period can be attributed to booster vaccination, maternal immunization, immunization for healthcare workers, global health initiatives. Major trends in the forecast period include personalized immunization schedules, combination vaccines, vaccine equity initiatives, digital health for immunization. request a sample here

How is the pertussis vaccine market segmented?

The pertussis vaccine market is segmented
1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine
2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine
3) By Application: Children, Adults, Infants
4) By End-User: Vaccination Centers, Hospitals, ClinicsFor further insights on the pertussis vaccine market
request a sample here

Which region has the largest share of the pertussis vaccine market? What are the other regions covered in the report?

North America was the largest region in the pertussis vaccine market in 2023. The regions covered in pertussis vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. request a sample here.

Who are the major players in the pertussis vaccine market?

Major players in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd., CSL Limited, Astellas Pharma US Inc., Sanofi Pasteur SA, Mitsubishi Tanabe Pharma America Inc., PT Kalbe Farma Tbk, CSL Seqirus, Walvax Biotechnology Co.Ltd., Biological E. Limited, Serum Institute of India, Bavarian Nordic AS, PT Bio Farma, Bharat Biotech International Limited, Takeda Pharmaceutical Company, Panacea Biotec Limited, Beijing Minhai Biotechnology Co. Ltd., Protein Sciences Corporation, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Gennova Biopharmaceuticals Ltd., Chiron Corporation. request a sample here.

What are the key trends in the pertussis vaccine market?

Major trend in the pertussis vaccine market - Innovative Approvals Bolster Major Companies In The Pertussis Vaccine Market. request a sample here.

What are the major opportunities in the pertussis vaccine market? What are the strategies for the pertussis vaccine market?

For detailed insights on the major opportunities and strategies in the pertussis vaccine market, request a sample here.

How does the pertussis vaccine market relate to the overall economy and other similar markets?

For detailed insights on pertussis vaccine market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the pertussis vaccine industry?

For detailed insights on the mergers and acquisitions in the pertussis vaccine industry, request a sample here.

What are the key dynamics influencing the pertussis vaccine market growth? SWOT analysis of the pertussis vaccine market.

For detailed insights on the key dynamics influencing the pertussis vaccine market growth and SWOT analysis of the pertussis vaccine industry, request a sample here.